TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 23795576

Group type: EXPERIMENTAL
Intervention: VAL/HCT fixed-dose combination (FDC) tablet
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: VAL + HCT (concomitant administration)
Number of subjects: 48

Group type: COMPARATOR
Intervention: VAL alone
Number of subjects: 48

Group type: COMPARATOR
Intervention: HCT alone
Number of subjects: 48
Study: 21091293

Group type: EXPERIMENTAL
Intervention: 15 g chicory native inulin
Number of subjects: 25

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 25
Study: 18364345

Group type: EXPERIMENTAL
Intervention: Internet-administered measures
Number of subjects: 319

Group type: COMPARATOR
Intervention: Telephone-administered measures
Number of subjects: 319
Study: 16263174

Group type: EXPERIMENTAL
Intervention: Fixed combination of latanoprost and timolol once daily in the evening
Number of subjects: 517

Group type: COMPARATOR
Intervention: Unfixed combination of latanoprost once daily in the evening and timolol in the morning and evening
Number of subjects: 517
Study: 14618044

Group type: EXPERIMENTAL
Intervention: Amiodarone
Number of subjects: 220

Group type: EXPERIMENTAL
Intervention: Amiodarone (4/5 day preoperative regimen)
Number of subjects: 220

Group type: EXPERIMENTAL
Intervention: Amiodarone (1-day preoperative regimen)
Number of subjects: 220

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 220
Study: 12607634

Group type: EXPERIMENTAL
Intervention: S + R (surgery plus radiotherapy)
Number of subjects: 495

Group type: COMPARATOR
Intervention: S (surgery alone)
Number of subjects: 495
Study: 10576171

Group type: EXPERIMENTAL
Intervention: Phase 1 treatment
Number of subjects: 242

Group type: COMPARATOR
Intervention: Control group (no phase 1 treatment)
Number of subjects: 242
Study: 8726552

Group type: EXPERIMENTAL
Intervention: Coital experience among girls (52.3%)
Number of subjects: 920

Group type: EXPERIMENTAL
Intervention: Coital experience among boys (41.4%)
Number of subjects: 920

Group type: EXPERIMENTAL
Intervention: Reasons for most recent intercourse among boys
Number of subjects: 920

Group type: EXPERIMENTAL
Intervention: Reasons for first sexual intercourse among both genders
Number of subjects: 920
Study: 2010577

Group type: EXPERIMENTAL
Intervention: Routine iron supplementation
Number of subjects: 2912

Group type: COMPARATOR
Intervention: Selective iron supplementation
Number of subjects: 2912
Study: 6306711

Group type: EXPERIMENTAL
Intervention: Zimelidine (300 mg)
Number of subjects: 6

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 6
Study: 30608440

Group type: EXPERIMENTAL
Intervention: Entecavir (ETV)
Number of subjects: 320

Group type: EXPERIMENTAL
Intervention: Tenofovir (TDF)
Number of subjects: 320

Group type: COMPARATOR
Intervention: Both ETV and TDF
Number of subjects: 320
Study: 30261680

Group type: EXPERIMENTAL
Intervention: MLT-enriched red wine (MLT+)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo red wine (PLC)
Number of subjects: 12
Study: 26894169

Group type: EXPERIMENTAL
Intervention: Aprotinin (1 ml of 10,000 Kallikrein Inactivator Units sub‐mucosally injected)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Isotonic saline (1 ml injected as control)
Number of subjects: 30
Study: 24245554

Group type: EXPERIMENTAL
Intervention: Ethinyl estradiol 0.03 mg/drospirenone (group 1)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Fructus agni casti (group 2)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control group (healthy women)
Number of subjects: 60
Study: 24469928

Group type: EXPERIMENTAL
Intervention: Metacognitive Therapy (MCT)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Delayed treatment control
Number of subjects: 20
Study: 21146657

Group type: EXPERIMENTAL
Intervention: Fondaparinux
Number of subjects: 12092
Study: 17430320

Group type: EXPERIMENTAL
Intervention: Pre-operative pain threshold measured using Pain Matcher (PM)
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: Pre-operative PM assessment of sensory threshold
Number of subjects: 39
Study: 15774256

Group type: EXPERIMENTAL
Intervention: OM-89 (immunotherapeutic); 1 capsule per day for 90 days, followed by 3 months without treatment, then 10 days in Months 7, 8, and 9.
Number of subjects: 453

Group type: COMPARATOR
Intervention: Placebo; 1 capsule per day for 90 days, followed by 3 months without treatment, then 10 days in Months 7, 8, and 9.
Number of subjects: 453
Study: 12200644

Group type: EXPERIMENTAL
Intervention: Home Osteocare device (active group)
Number of subjects: 157

Group type: COMPARATOR
Intervention: Sham group (performed similar motion without triggering impact force)
Number of subjects: 157

Group type: COMPARATOR
Intervention: Control group (no prescribed heel drop exercise)
Number of subjects: 157
Study: 10099066

Group type: EXPERIMENTAL
Intervention: Claritin‐D 24 Hour (loratadine 10 mg and pseudoephedrine sulfate 240 mg)
Number of subjects: 469

Group type: EXPERIMENTAL
Intervention: Claritin‐D 12 Hour (loratadine 5 mg and pseudoephedrine sulfate 120 mg)
Number of subjects: 469

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 469
Study: 7654944

Group type: EXPERIMENTAL
Intervention: Exercise group
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (nonexercise)
Number of subjects: 0
Study: 2568776

Group type: EXPERIMENTAL
Intervention: iopromide
Number of subjects: 100

Group type: COMPARATOR
Intervention: iohexol
Number of subjects: 100
Study: 341283

Group type: EXPERIMENTAL
Intervention: Ferastral (iron-poly (sorbitol-gluconic acid) complex)
Number of subjects: 38

Group type: COMPARATOR
Intervention: Iron-dextran (Total Dose Infusion)
Number of subjects: 38
Study: 29702630

Group type: EXPERIMENTAL
Intervention: Game-based VR canoe paddling training for 30 minutes each day, three times per week, for five weeks
Number of subjects: 30

Group type: COMPARATOR
Intervention: Conventional rehabilitation program
Number of subjects: 30
Study: 28061841

Group type: EXPERIMENTAL
Intervention: 8-week preoperative supervised neuromuscular exercise program
Number of subjects: 165

Group type: COMPARATOR
Intervention: Control group (no preoperative exercise)
Number of subjects: 165
Study: 26194125

Group type: EXPERIMENTAL
Intervention: Benachio Q solution®
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study: 23040887

Group type: EXPERIMENTAL
Intervention: Mepolizumab (750 mg)
Number of subjects: 78
Study: 21914196

Group type: EXPERIMENTAL
Intervention: K-wire fixation
Number of subjects: 390

Group type: COMPARATOR
Intervention: locking-plate fixation
Number of subjects: 390
Study: 18326603

Group type: EXPERIMENTAL
Intervention: Barley or rye kernel breakfasts
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Barley kernel evening meal
Number of subjects: 12

Group type: COMPARATOR
Intervention: White‐wheat bread
Number of subjects: 12
Study: 16599766

Group type: EXPERIMENTAL
Intervention: Intentional body rocking
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Sitting postures
Number of subjects: 0

Group type: COMPARATOR
Intervention: Center of pressure (COP) motion
Number of subjects: 0
Study: 12687836

Group type: EXPERIMENTAL
Intervention: Bepridil, 200 mg/day (n = 14)
Number of subjects: 52

Group type: COMPARATOR
Intervention: Class Ic antiarrhythmic drugs (Flecainide, 100 to 200 mg/day (n = 15) or Pilsicainide, 75 to 150 mg/day (n = 23))
Number of subjects: 52

Group type: EXPERIMENTAL
Intervention: Bepridil
Number of subjects: 52

Group type: COMPARATOR
Intervention: Class Ic antiarrhythmic drugs
Number of subjects: 52
Study: 11423497

Group type: EXPERIMENTAL
Intervention: Conventional or intensive glucose control policies
Number of subjects: 2999
Study: 9261765

Group type: EXPERIMENTAL
Intervention: 0.5% dapiprazole (1 drop)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: 0.5% dapiprazole (2 drops followed by 2 additional drops 5 minutes later)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study: 8388332

Group type: EXPERIMENTAL
Intervention: Acupuncture and transcutaneous stimulation (TES)
Number of subjects: 42

Group type: COMPARATOR
Intervention: Moderate-dose fentanyl
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: Combination of acupuncture and TES with moderate-dose fentanyl
Number of subjects: 42

Group type: COMPARATOR
Intervention: Acupuncture and TES
Number of subjects: 42
Study: 3812308

Group type: COMPARATOR
Intervention: Propranolol (mean 371 mg)
Number of subjects: 21

Group type: COMPARATOR
Intervention: Diltiazem (mean 307 mg)
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Both agents
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Diltiazem
Number of subjects: 21
Study: 2774228

Group type: EXPERIMENTAL
Intervention: Oral transmucosal fentanyl citrate (OTFC) 15-20 micrograms/kg (group B)
Number of subjects: 55

Group type: COMPARATOR
Intervention: Placebo lollipop (group C)
Number of subjects: 55

Group type: COMPARATOR
Intervention: No premedication (group A)
Number of subjects: 55

Group type: EXPERIMENTAL
Intervention: Oral transmucosal fentanyl citrate (OTFC) (group B)
Number of subjects: 55
Study: 30641827

Group type: EXPERIMENTAL
Intervention: Hyperglycemia
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Hyperglycemia plus dyslipidemia
Number of subjects: 120

Group type: COMPARATOR
Intervention: Control (normoglycemia and normolipidemia)
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Comparison between hyperglycemia and hyperglycemia plus dyslipidemia
Number of subjects: 120
Study: 28801235

Group type: EXPERIMENTAL
Intervention: Electronic frailty screening instrument followed by standard GP care
Number of subjects: 3092

Group type: EXPERIMENTAL
Intervention: Electronic frailty screening instrument followed by nurse-led care program
Number of subjects: 3092

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 3092

Group type: EXPERIMENTAL
Intervention: Screening plus nurse-led care
Number of subjects: 3092
Study: 25222800

Group type: EXPERIMENTAL
Intervention: Cognitive behavior therapy for insomnia (CBTI‐BP; n = 17)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Psychoeducation (PE; n = 13)
Number of subjects: 30
Study: 23780458

Group type: EXPERIMENTAL
Intervention: Endosonography (esophageal or endobronchial ultrasonography) with aspiration of intrathoracic lymph nodes
Number of subjects: 304

Group type: COMPARATOR
Intervention: Bronchoscopy with transbronchial and endobronchial lung biopsies
Number of subjects: 304

Group type: EXPERIMENTAL
Intervention: Bronchoalveolar lavage
Number of subjects: 304

Group type: COMPARATOR
Intervention: Bronchoscopy
Number of subjects: 304

Group type: EXPERIMENTAL
Intervention: Endosonography
Number of subjects: 304
Study: 21075378

Group type: EXPERIMENTAL
Intervention: One-incision modified Watson-Jones approach
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: Two-incision approach
Number of subjects: 26

Group type: COMPARATOR
Intervention: THA subjects (combined group)
Number of subjects: 26
Study: 19709502

Group type: EXPERIMENTAL
Intervention: 1 g/d of eicosapentaenoic acid (EPA) for 8 weeks
Number of subjects: 57

Group type: COMPARATOR
Intervention: Placebo for 8 weeks
Number of subjects: 57
Study: 17287149

Group type: EXPERIMENTAL
Intervention: Exercise intervention (n=87)
Number of subjects: 173

Group type: COMPARATOR
Intervention: Stretching-control group (n=86)
Number of subjects: 173
Study: 12694639

Group type: EXPERIMENTAL
Intervention: Midcycle assessment in NC women
Number of subjects: 54

Group type: EXPERIMENTAL
Intervention: Midcycle assessment in OC women
Number of subjects: 54

Group type: EXPERIMENTAL
Intervention: All cycle phases in OC women and participants not in intimate relationships
Number of subjects: 54

Group type: EXPERIMENTAL
Intervention: All cycle phases in men and single women
Number of subjects: 54

Group type: EXPERIMENTAL
Intervention: All cycle phases in engaged women
Number of subjects: 54

Group type: EXPERIMENTAL
Intervention: All cycle phases in men
Number of subjects: 54

Group type: EXPERIMENTAL
Intervention: Luteal phase in NC women
Number of subjects: 54
Study: 10571599

Group type: EXPERIMENTAL
Intervention: SB-207266-A (20 mg)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 18
Study: 8768852

Group type: EXPERIMENTAL
Intervention: Propranolol (10(‐4) mol/L)
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: Phentolamine (10(‐4) mol/L)
Number of subjects: 33

Group type: COMPARATOR
Intervention: Control (no intervention)
Number of subjects: 33
Study: 1993796

Group type: EXPERIMENTAL
Intervention: Digoxin
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study: 6761905

Group type: EXPERIMENTAL
Intervention: Oxamniquine (20mg/kg body-weight)
Number of subjects: 91

Group type: COMPARATOR
Intervention: Placebo (Control Group)
Number of subjects: 91
Study: 30335419

Group type: EXPERIMENTAL
Intervention: 6-week mindfulness training program
Number of subjects: 60

Group type: COMPARATOR
Intervention: Half-day mindfulness training seminar
Number of subjects: 60
Study: 28511794

Group type: EXPERIMENTAL
Intervention: Modified sampling method (distal end of the epidural catheter)
Number of subjects: 86

Group type: COMPARATOR
Intervention: Traditional sampling method (proximal end of the epidural catheter)
Number of subjects: 86
Study: 25582924

Group type: COMPARATOR
Intervention: Standard number of waves/session (mean 2858.3±302.8) using Dornier lithotripter U/15/50
Number of subjects: 332

Group type: EXPERIMENTAL
Intervention: Expanded number of waves/session (mean 6728.9±889.6) using Siemens Modularis lithotripter
Number of subjects: 332
Study: 24244335

Group type: EXPERIMENTAL
Intervention: Biodegradable polymer biolimus-eluting stents (BES)
Number of subjects: 11015

Group type: COMPARATOR
Intervention: Durable polymer drug-eluting stents (DES)
Number of subjects: 11015
Study: 22111914

Group type: EXPERIMENTAL
Intervention: Laparoscopic surgery with fast track perioperative treatment and Xelox chemotherapy
Number of subjects: 340

Group type: EXPERIMENTAL
Intervention: Open surgery with fast track perioperative treatment and Xelox chemotherapy
Number of subjects: 340

Group type: EXPERIMENTAL
Intervention: Laparoscopic surgery with conventional perioperative treatment and mFolfox6 chemotherapy
Number of subjects: 340

Group type: EXPERIMENTAL
Intervention: Open surgery with conventional perioperative treatment and mFolfox6 chemotherapy
Number of subjects: 340
Study: 19395457

Group type: EXPERIMENTAL
Intervention: Atacicept (single dose: 3, 9 or 18 mg/kg; or multiple dose: 2 x 9 mg/kg)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Atacicept (i.v.)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Atacicept
Number of subjects: 24

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24
Study: 16467018

Group type: EXPERIMENTAL
Intervention: Etanercept 25 mg or 50 mg twice weekly (BIW) or 25 mg once weekly
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo (original placebo patients received 25 mg BIW for the final 12 weeks of the double‐blind period)
Number of subjects: 0
Study: 14748943

Group type: EXPERIMENTAL
Intervention: Micronised, dispersible ferric pyrophosphate (5 mg Fe) in infant cereal
Number of subjects: 20

Group type: COMPARATOR
Intervention: Ferrous sulfate (5 mg Fe) in infant cereal
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Micronised, dispersible ferric pyrophosphate (5 mg Fe) in yoghurt drink
Number of subjects: 20

Group type: COMPARATOR
Intervention: Ferrous sulfate (5 mg Fe) in yoghurt drink
Number of subjects: 20
Study: 10627323

Group type: EXPERIMENTAL
Intervention: Rally drivers
Number of subjects: 18

Group type: COMPARATOR
Intervention: Reference group (population sample)
Number of subjects: 18
Study: 9369270

Group type: EXPERIMENTAL
Intervention: Infusion of 5.0 ng Ang II x kg(‐1) x min(‐1) (pressor dose)
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Infusion of 1.0 ng Ang II x kg(‐1) x min(‐1) (subpressor dose)
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Infusion of Ang II during oral glucose tolerance test
Number of subjects: 19
Study: 1572493

Group type: EXPERIMENTAL
Intervention: Laparoscopic surgery (laparoscopy)
Number of subjects: 105

Group type: COMPARATOR
Intervention: Laparotomy (control)
Number of subjects: 105
Study: 3883177

Group type: EXPERIMENTAL
Intervention: Intramuscular benzathine penicillin 2.4 million U weekly for three weeks (total 7.2 million U)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Intravenous penicillin G 20 million U a day for 10 days
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo (saline)
Number of subjects: 20
Study: 30636561

Group type: EXPERIMENTAL
Intervention: Low-dose prasugrel (5 mg daily)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Clopidogrel (75 mg daily)
Number of subjects: 0
Study: 30547863

Group type: EXPERIMENTAL
Intervention: Sous vide preparation of pork roast from an organic farm
Number of subjects: 11

Group type: COMPARATOR
Intervention: Oven cooking of pork roast from an organic farm
Number of subjects: 11

Group type: COMPARATOR
Intervention: Sous vide preparation of pork roast from an ordinary pig
Number of subjects: 11

Group type: COMPARATOR
Intervention: Oven cooking of pork roast from an ordinary pig
Number of subjects: 11
Study: 28838480

Group type: EXPERIMENTAL
Intervention: Self-Expanding Stent (SE)
Number of subjects: 660

Group type: COMPARATOR
Intervention: Balloon-Expandable Stent (BE)
Number of subjects: 660
Study: 26633806

Group type: EXPERIMENTAL
Intervention: CTZ (Chemotherapy + Zoledronic Acid)
Number of subjects: 188

Group type: COMPARATOR
Intervention: CT (Chemotherapy)
Number of subjects: 188

Group type: EXPERIMENTAL
Intervention: CTZ (Chemotherapy + Zoledronic Acid) in postmenopausal patients
Number of subjects: 188

Group type: COMPARATOR
Intervention: CT (Chemotherapy) in postmenopausal patients
Number of subjects: 188

Group type: EXPERIMENTAL
Intervention: CTZ (Chemotherapy + Zoledronic Acid) in triple-negative breast cancer patients
Number of subjects: 188

Group type: COMPARATOR
Intervention: CT (Chemotherapy) in triple-negative breast cancer patients
Number of subjects: 188
Study: 23403043

Group type: EXPERIMENTAL
Intervention: Internet-based recruitment via Google advertising
Number of subjects: 1699

Group type: EXPERIMENTAL
Intervention: Internet-based recruitment through trustworthy organizations and websites
Number of subjects: 1699

Group type: COMPARATOR
Intervention: Less effective recruitment techniques
Number of subjects: 1699
Study: 21377179

Group type: EXPERIMENTAL
Intervention: Aerobic exercise
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Resistance exercise
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Combined exercise (aerobic and resistance)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Control group (no exercise)
Number of subjects: 48
Study: 18644036

Group type: EXPERIMENTAL
Intervention: almotriptan 12.5 mg combined with aceclofenac 100 mg
Number of subjects: 112

Group type: COMPARATOR
Intervention: triptan-placebo
Number of subjects: 112
Study: 17176279

Group type: EXPERIMENTAL
Intervention: IM carbetocin (100 microgram)
Number of subjects: 329

Group type: COMPARATOR
Intervention: IM syntometrine (1 ml, a mixture of 5 iu oxytocin and 0.5 mg ergometrine)
Number of subjects: 329

Group type: EXPERIMENTAL
Intervention: IM carbetocin
Number of subjects: 329
Study: 14971608

Group type: EXPERIMENTAL
Intervention: Preoperative DRF >= 30% (group I, n=22)
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Preoperative DRF < 30% (group II, n=10)
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Preoperative drainage half-time
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Mean DRF preoperative
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Mean DRF postoperative
Number of subjects: 32
Study: 10761802

Group type: EXPERIMENTAL
Intervention: Intensive insulin treatment (Group 1)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Conventional therapy only (Group 2)
Number of subjects: 48
Study: 9709272

Group type: EXPERIMENTAL
Intervention: Breast cancer screening (four mammographic examinations at two-year intervals and seven annual clinical examinations)
Number of subjects: 21774

Group type: EXPERIMENTAL
Intervention: Earlier screening (before age 50)
Number of subjects: 21774
Study: 8454464

Group type: EXPERIMENTAL
Intervention: Relaxation training (two sessions at weeks 1 and 2, follow-up at week 5)
Number of subjects: 137

Group type: COMPARATOR
Intervention: Control group (theory analysis presentation)
Number of subjects: 137
Study: 3779343

Group type: EXPERIMENTAL
Intervention: Caffeine (5 mg.kg‐1)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo (225 mg methylcellulose)
Number of subjects: 12
Study: 29757933

Group type: EXPERIMENTAL
Intervention: Increased physical activity and support for healthy eating
Number of subjects: 650

Group type: COMPARATOR
Intervention: Control group (standard physical education curriculum)
Number of subjects: 650
Study: 27903564

Group type: EXPERIMENTAL
Intervention: Tailored intervention based on a discussion informed by responses to the MAQ, Beliefs about Medicines Questionnaire‐Specific and Brief Illness Perception Questionnaire.
Number of subjects: 120

Group type: COMPARATOR
Intervention: Control group (no tailored intervention).
Number of subjects: 120
Study: 23953392

Group type: EXPERIMENTAL
Intervention: Electronic version of the WOMAC questionnaire
Number of subjects: 53

Group type: COMPARATOR
Intervention: Paper version of the WOMAC questionnaire
Number of subjects: 53

Group type: EXPERIMENTAL
Intervention: Electronic version of the SF-12 questionnaire (PCS)
Number of subjects: 53

Group type: COMPARATOR
Intervention: Paper version of the SF-12 questionnaire (PCS)
Number of subjects: 53

Group type: EXPERIMENTAL
Intervention: Electronic version of the SF-12 questionnaire (MCS)
Number of subjects: 53

Group type: COMPARATOR
Intervention: Paper version of the SF-12 questionnaire (MCS)
Number of subjects: 53
Study: 21719357

Group type: EXPERIMENTAL
Intervention: 6-month behavioral intervention
Number of subjects: 36

Group type: COMPARATOR
Intervention: Wait list control group
Number of subjects: 36
Study: 21110503

Group type: EXPERIMENTAL
Intervention: Antibiotic eye drops, used 4 times a day for 5 days before surgery
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Antiseptic eye drops, used 4 times a day for 5 days before surgery
Number of subjects: 0

Group type: COMPARATOR
Intervention: Untreated group (control)
Number of subjects: 0
Study: 18054894

Group type: EXPERIMENTAL
Intervention: ACT-Values Protocol
Number of subjects: 30

Group type: COMPARATOR
Intervention: CONT-Values Protocol
Number of subjects: 30

Group type: COMPARATOR
Intervention: No-Values Protocol
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: ACT with Coping Strategy (Defusion)
Number of subjects: 30

Group type: COMPARATOR
Intervention: CONT with Coping Strategy (Suppression)
Number of subjects: 30
Study: 15919047

Group type: EXPERIMENTAL
Intervention: Low traffic condition (afternoon session)
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Heavy traffic condition (evening session)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Low traffic condition (evening session)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Heavy traffic condition (afternoon session)
Number of subjects: 36